Mycoplasma pulmonis inhibits electrogenic ion transport across murine tracheal epithelial cell monolayers.
Murine chronic respiratory disease is characterized by persistent colonization of tracheal and bronchial epithelial cell surfaces by Mycoplasma pulmonis, submucosal and intraluminal immune and inflammatory cells, and altered airway activity. To determine the direct effect of M. pulmonis upon transepithelial ion transport in the absence of immune and inflammatory cell responses, primary mouse tracheal epithelial cell monolayers (MTEs) were apically infected and assayed in Ussing chambers. M. pulmonis-infected MTEs, but not those infected with a nonmurine mycoplasma, demonstrated reductions in amiloride-sensitive Na+ absorption, cyclic AMP, and cholinergic-stimulated Cl- secretion and transepithelial resistance. These effects were shown to require interaction of viable organisms with the apical surface of the monolayer and to be dependent upon organism number and duration of infection. Altered transport due to M. pulmonis was not merely a result of epithelial cell death as evidenced by the following: (i) active transport of Na+ and Cl-, albeit at reduced rates; (ii) normal cell morphology, including intact tight junctions, as demonstrated by electron microscopy; (iii) maintenance of a mean transepithelial resistance of 440 omega/cm2; and (iv) lack of leakage of fluid from the basolateral to the apical surface of the monolayer. Alteration in epithelial ion transport in vitro is consistent with impaired pulmonary clearance and altered airway function in M. pulmonis-infected animals. Furthermore, the ability of M. pulmonis to alter transport without killing the host cell may explain its successful parasitism and long-term persistence in the host. Further study of the MTE-M. pulmonis model should elucidate the molecular mechanisms which mediate this reduction in transepithelial ion transport.
Lambert
L C
LC
Department of Microbiology, University of Alabama at Birmimgham, 35294, USA.
Trummell
H Q
HQ
Singh
A
A
Cassell
G H
GH
Bridges
R J
RJ
D000584:Amiloride / Q000378:metabolism; D000818:Animals; D016764:Cell Polarity; D048429:Cell Size; D002478:Cells, Cultured; D002712:Chlorides / Q000378:metabolism*; D018678:Cholinergic Agents / Q000378:metabolism; D000242:Cyclic AMP / Q000378:metabolism; D004847:Epithelial Cells / Q000166:cytology / Q000648:ultrastructure; D017136:Ion Transport; D051379:Mice; D009175:Mycoplasma Infections / Q000378:metabolism*; D012964:Sodium / Q000493:pharmacokinetics*; D013045:Species Specificity; D019108:Tight Junctions / Q000378:metabolism / Q000648:ultrastructure; D014132:Trachea / Q000166:cytology
D002712:Chlorides; D018678:Cholinergic Agents; D000584:Amiloride; D012964:Sodium; D000242:Cyclic AMP